Navigation Links
Study finds high Rx burden for bipolar patients
Date:2/4/2014

A study of 230 patients with bipolar I disorder whose symptoms were severe enough to warrant admission to a Rhode Island psychiatric hospital in 2010 reveals that more than a third were there despite taking four or more psychiatric medications. Including medicines for other conditions, such as cardiometabolic diseases, the average patient came to the hospital taking six different drugs.

The study quantifies a difficult outcome for many patients with this difficult-to-treat disorder, said study lead author Lauren Weinstock of the Alpert Medical School of Brown University and of Butler Hospital, where the patients were admitted: They accrue a high burden of prescriptions each with their own side effects, with often unknown interactions, and with a complexity that can result in not taking the medications as prescribed. This medication burden also includes high overall cost to patients and the healthcare system.

Yet for those patients who've needed to come to the hospital, these complex combinations of drugs haven't proven sufficiently effective, Weinstock said.

The study, published online Feb. 1 in the journal Psychiatry Research, also reports the likelihood of a high medication burden was significantly greater for women than men.

"The high rate of complex polypharmacy reflects the enormous challenge of symptom management that we currently face for bipolar disorder," said Weinstock, an assistant professor of psychiatry and human behavior at Brown. "Without many treatment alternatives, this is where we are as a field. It is important for us to advance science and treatment of bipolar disorder so that this medication burden can be minimized for our patients."

Weinstock, who studies psychotherapy as a complement to medical treatment at Butler, said she and her colleagues became motivated to quantify the pharmacological burden for those with biploar disorder after witnessing it anecdotally among patients.

'Complex polypharmacy'

Weinstock and her co-authors therefore compiled data from patients' hospital admission records in the calendar year 2010. The only inclusion criteria were being 18 or older, and having a diagnosis of bipolar I disorder at hospital admission and discharge.

"The data aren't confounded by someone's active participation in a research study," Weinstock said. "We wanted to measure what was happening in routine community practice."

What they found is that when they came to the hospital, patients were taking an average of 3.3 psychotropic drugs and an average of 5.9 drugs overall. Nearly one in five patients weren't on any psychotropic drugs, but more than half were taking 3 or more and more than a third were taking four or more, meeting the definition of "complex polypharmacy."

The complex polypharmacy rate of 36 percent is higher than in a few previous studies that looked at bipolar patients, Weinstock said, because those studies did not always include all psychotropic medications, such as the commonly prescribed antianxiety medications.

Weinstock noted that because no clinical trial of bipolar medications has ever tested more than two drugs in combination, prescribing three or four exceeds practices supported by the field.

"By definition that's not evidence-based treatment," she said.

No prior studies had looked at the total medication burden, rather than just that of pyschotropics. It's important to do so, Weinstock said, because cardiometabolic diseases, in particular, are often concurrent with bipolar disorder. Among the 230 patients in the study, for example, about half had such medical problems.

More so for women

Women, the data showed, were 58 percent of the total patients, but 68 percent of those with complex polypharmacy. Women were more likely to be on an antidepressant, antianxiety medication, and on stimulants, all of which which remain somewhat controversial in bipolar disorder treatment, Weinstock said.

The proportion of women taking an antidepressant (43 percent) was nearly twice that of men (23 percent). The significance of the gender disparities in the study endured even after statistically controlling for depressive symptoms in their diagnosis.

"Women weren't prescribed more medications just because they were more likely to be depressed," Weinstock said. "This finding raises the question of what other factors may influence higher rates of polypharmacy among female patients, such as patient or provider characteristics."

But the study does not provide information that could reveal why that is.

Still, combined with other studies and epidemiological data, the study points to a trend that needs improving, Weinstock and her co-authors wrote: "This increased reliance on polypharmacy does not appear to be contributing to decreased rates of illness chronicity or functional impairment in BD."


'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert  

Related medicine news :

1. Using susceptibility-weighted imaging to study concussion in college ice hockey players
2. New study explores contributors to excess infant mortality in the US South
3. NIH study describes new method for tracking T cells in HIV patients
4. NIH study offers insight into why cancer incidence increases with age
5. Tighter economic regulation needed to reverse obesity epidemic -- study
6. Kessler Foundation MS researchers study predictors of employment status
7. U of Maryland study: Partnership may help address cancer, health disparities
8. Study uncovers molecular keys to invasive bladder cancer
9. Study finds mammography beneficial for younger women
10. Infection control practices not adequately implemented at many hospital ICUs: study
11. Study: Oropharyngeal cancer on the rise in young adults
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study finds high Rx burden for bipolar patients
(Date:7/25/2017)... ... July 25, 2017 , ... Facing medical needs with a newborn boy this ... of a new benefit for employees that is uncommon in American business: 12 weeks ... supports me and other employees as new parents. It keeps our family life more ...
(Date:7/24/2017)... ... July 24, 2017 , ... ...      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins Will, ... celebrate the structural topping out of the new Destination Medical Building located ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response ... California Department of Health Care Services, will facilitate the development of a hub ...
(Date:7/24/2017)... Cleveland, OH (PRWEB) , ... July 24, 2017 , ... ... OH on the life-altering neurological condition called essential tremor (ET). The seminar will take ... at 5800 Rockside Woods Blvd., Independence, OH. The program will run from 9 a.m. ...
(Date:7/24/2017)... ... , ... Independence Blue Cross (Independence) and ... program, have signed a five-year agreement that will marshal resources from both organizations ... patients receive. The agreement also signifies Jefferson Health officially joining the Independence ...
Breaking Medicine News(10 mins):
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
(Date:7/13/2017)... -- RK Logistics Group, Inc. was awarded California ... Fremont, CA headquarters facility where it provides ... San Jose for hi-tech, pharmaceutical and biomedical ... with its Fremont Innovation District, is excited to strategically partner ... to the hundreds of biotech, pharma and biomed companies throughout ...
Breaking Medicine Technology: